Pediatric population (aged 3-11 years) received primary inactivated SARS-CoV-2 vaccination prior to infection exhibiting robust humoral immune response following infected with Omicron variant: a study conducted in Beijing

Pediatric population (aged 3-11 years) received primary inactivated SARS-CoV-2 vaccination prior to infection exhibiting robust humoral immune response following infected with Omicron variant: a study conducted in Beijing

ObjectiveAnalysis of SARS-CoV-2 IgG antibody and neutralizing antibody levels following SARS-CoV-2 infection in children aged 3-11 years, comparing those who had received the inactivated SARS-CoV-2 vaccine to those who were unvaccinated prior to infection, provides evidence for public health centers...

Full description

Bibliographic Details
Main Authors: Jing Li, Jingjing Li, Shuzhi Dai, Li Dang, Lin Wang, Ling Cao, Xiaobo Chen, Ying Wang, Menglei Ge, Weijie Liu, Qinwei Song, Wenjian Xu, Lijuan Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Immunology
Subjects:
vaccination
COVID-19
children
SARS-CoV-2 infection
neutralizing antibody
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1269665/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1269665/full

Similar Items